PROPHASE LABS INC. -

ProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Time

04 May 2023 08:30:01 By Nasdaq GlobeNewswire

ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers

03 May 2023 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023

28 Apr 2023 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Launch of Redesigned Corporate Website

25 Apr 2023 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023

18 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022

28 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Host 2022 Year End Financial Results Conference Call on Tuesday, March 28, 2023 at 11:00 a.m. Eastern Time

21 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces New $6 Million Stock Repurchase Program

15 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test 

13 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs’ Nebula Genomics Subsidiary Introduces Lowest Ever NGS Pricing of $249 for its Whole Genome Sequencing DNA Test

07 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Collaboration with mProbe, Inc. and Mayo Clinic for the Continuing Development of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test

01 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC)

22 Feb 2023 08:00:02 By Nasdaq GlobeNewswire

ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science

16 Feb 2023 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Plans for Major Expansion of its Pharmaloz Manufacturing, Inc. Subsidiary to Meet Growing Demand

15 Feb 2023 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy

06 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test

05 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test

19 Dec 2022 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022

30 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Record Third Quarter 2022 Financial Results

10 Nov 2022 08:00:04 By Nasdaq GlobeNewswire

ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute

08 Nov 2022 08:00:01 By Nasdaq GlobeNewswire